Oncology Institute (TOI) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to -$6.21.
- Oncology Institute's Debt to Equity fell 20499.55% to -$6.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.21, marking a year-over-year decrease of 20499.55%. This contributed to the annual value of $25.95 for FY2024, which is 160426.18% up from last year.
- As of Q3 2025, Oncology Institute's Debt to Equity stood at -$6.21, which was down 20499.55% from -$8.35 recorded in Q2 2025.
- Oncology Institute's 5-year Debt to Equity high stood at $25.95 for Q4 2024, and its period low was -$8.35 during Q2 2025.
- Its 5-year average for Debt to Equity is $3.06, with a median of $1.09 in 2023.
- In the last 5 years, Oncology Institute's Debt to Equity soared by 3715386.37% in 2022 and then tumbled by 37111.11% in 2025.
- Quarter analysis of 5 years shows Oncology Institute's Debt to Equity stood at $0.0 in 2021, then skyrocketed by 37153.86% to $0.65 in 2022, then skyrocketed by 132.63% to $1.52 in 2023, then skyrocketed by 1604.26% to $25.95 in 2024, then plummeted by 123.92% to -$6.21 in 2025.
- Its last three reported values are -$6.21 in Q3 2025, -$8.35 for Q2 2025, and $14.58 during Q1 2025.